Fibromyalgia rapid screening tool: linguistic adaptation of the Russian version

Nasonova T.I.

Sechenov First Moscow State Medical University

Bakhtadze M.A.

Pirogov Russian National Research Medical University;
Center for Manual Therapy

Mukhametzyanova A.Kh.

Sechenov First Moscow State Medical University

Isaikin A.I.

Sechenov First Moscow State Medical University

Fibromyalgia rapid screening tool: linguistic adaptation of the Russian version

Authors:

Nasonova T.I., Bakhtadze M.A., Mukhametzyanova A.Kh., Isaikin A.I.

More about the authors

Journal: Russian Journal of Pain. 2022;20(3): 16‑20

DOI: 10.17116/pain20222003116

Downloaded: 501

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Nasonova TI, Bakhtadze MA, Mukhametzyanova AKh, Isaikin AI. Fibromyalgia rapid screening tool: linguistic adaptation of the Russian version. Russian Journal of Pain. 2022;20(3):16‑20. (In Russ.)
https://doi.org/10.17116/pain20222003116

Подписка 2025-2 (Russian Journal of Pain)

Close metadata

INTRODUCTION

The original questionnaire Fibromyalgia Rapid Screening Tool (FiRST) was developed in 2009 and adapted in various countries in various languages. However, there is no adapted Russian-language version of FiRST.

OBJECTIVE

Linguistic adaptation of the Russian-language version of FiRST.

MATERIAL AND METHODS

Linguistic adaptation of the Russian-language version of FiRST was carried out in five stages: I) direct translation by three translators; II) development of one version of direct translation; III) reverse translation by two native English speakers; IV) development of one reverse version and its discussion by a committee of experts; V) preliminary testing of the Russian version in three groups: 50 patients with fibromyalgia; 30 patients with chronic non — specific back pain; 30 people who do not complain of pain syndrome.

RESULTS

A Russian-language version of FiRST has been developed to detect fibromyalgia. The use of the questionnaire in 50 patients with fibromyalgia, 30 patients with chronic nonspecific back pain, 30 people without back and limb pain did not cause comments from either the patients or the doctors who examined the patients. Filling out the Russian-language version of FiRST took no more than 3 minutes.

CONCLUSION

The Russian-language version of FiRST can be used to evaluate its psychometric properties in clinical practice.

Keywords:

chronic widespread pain

fibromyalgia

fibromyalgia rapid screening tool

linguistic adaptation

Authors:

Nasonova T.I.

Sechenov First Moscow State Medical University

Bakhtadze M.A.

Pirogov Russian National Research Medical University;
Center for Manual Therapy

Mukhametzyanova A.Kh.

Sechenov First Moscow State Medical University

Isaikin A.I.

Sechenov First Moscow State Medical University

Received:

17.04.2022

Accepted:

10.05.2022

List of references:

Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, Fitzcharles MA, Paiva ES, Staud R, Sarzi-Puttini P, Buskila D, Macfarlane GJ. AAPT Diagnostic Criteria for Fibromyalgia. The Journal of Pain. 2019;20(6):611-628. https://doi.org/10.1016/j.jpain.2018.10.008
Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: Sex, pain threshold, and fibromyalgia symptoms. The Journal of Rheumatology. 1995;22(1):151-156. PMID: 7699662. https://pubmed.ncbi.nlm.nih.gov/7699662
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism. 1990;33(2):160-172. https://doi.org/10.1002/art.1780330203
Davydov OS, Glebov MV. Fibromyalgia. Russian Journal of Pain. 2020;18(3):66-74. (In Russ.). https://doi.org/10.17116/pain20201803166
Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubre JP, Le Lay K, Taïeb C. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis and Rheumatism. 2008;58(3):895-902. https://doi.org/10.1002/art.23265
Perrot S, Bouhassira D, Fermanian J. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010;150(2):250-256. https://doi.org/10.1016/j.pain.2010.03.034
Collado A, Torres X, Messina OD, Vidal LF, Clark P, Ríos C, Solé E, Arias A, Perrot S, Salomon PA. The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American Countries. Pain Medicine. 2016;17:931-939. https://doi.org/10.1093/pm/pnv065
Zis P, Brozou V, Stavropoulou E, Argyra E, Siafaka I, Kararizou E, Bouhassira D, Perrot S, Zis V, Vadalouca A.Validation of the Greek Version of the Fibromyalgia Rapid Screening Tool. Pain Practice. 2017;17(7):925-929. https://doi.org/10.1111/papr.12545
Celiker R, Altan L, Rezvani A, Aktas I, Tastekin N, Dursun E, Dursun N, Sarıkaya S, Ozdolap S, Akgun K, Zateri C, Birtane M. Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST). Journal of Physical Therapy Science. 2017;29(2):340-344. https://doi.org/10.1589/jpts.29.340
Choi BCK, Pak AWP. A catalog of biases in questionnaires. Preventing chronic disease. 2005;2(1):A13. PMID: 15670466; PMCID: PMC1323316. https://pubmed.ncbi.nlm.nih.gov/15670466
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186-3191. https://doi.org/10.1097/00007632-200012150-00014
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. Journal of Clinical Epidemiology. 1993;46(12):1417-1432. https://doi.org/10.1016/0895-4356(93)90142-n
Hall DA, Zaragoza Domingo S, Hamdache LZ, Manchaiah V, Thammaiah S, Evans C, Wong LLN. A good practice guide for translating and adapting hearing-related questionnaires for different languages and cultures. International Journal of Audiology. 2018;57(3):161-175. https://doi.org/10.1080/14992027.2017.1393565
PRO. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes. 2006;4:79. https://doi.org/10.1186/1477-7525-4-79
Leonova MV. Patient-reported outcomes in clinical studies. Kachestvennaya klinicheskaya praktika. 2016;(2):38-45. (In Russ.). https://www.clinvest.ru/jour/article/view/45?locale=ru_RU

Close metadata